Health
MDBriefCase Establishes World-Class Oncology Scientific Steering Committee
Leading global oncology professionals to identify areas of opportunity for educational programs worldwide TORONTO, Feb. 9, 2021 /PRNewswire/ -- MDBriefCase Group Inc. ("MDBriefCase"), a global provider of leading online continuing medical education and professional development for healthcare pro...
2021-02-09 19:00
1177
Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China
SHENZHEN, China, Feb. 9, 2021 /PRNewswire/ -- Aesthetic Medical International Holdings Group Limited (the "Company" or "AIH", Nasdaq: AIH), a leading provider of aesthetic medical services inChina, and Forbes China have jointly releasedthe Chinese Aesthetic Treatment Industry White Paper 2020 (t...
2021-02-09 18:00
2901
Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant
SHANGHAI, Feb. 8, 2021 /PRNewswire/ -- On February 7, 2021, scientists from Jemincare Shanghai Research Institute published a preprint paper on BioRxiv, the paper entitled "A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prop...
2021-02-09 11:18
1952
Cooperation Agreement with Terumo Blood And Cell Technologies to Promote and Sell Osteopore Products
Highlights: * Cooperation Agreement with Terumo Blood and Cell Technologies to promote and sell both companies complementary regenerative products inAsia-Pacific. * Terumo Blood and Cell Technologies' products will be used to concentrate a patient's bone marrow and mixed into Osteopore scaffo...
2021-02-08 21:21
2202
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onFebruary 8, 2021, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Liv...
2021-02-08 21:00
7774
CareCapital appoints Bindusaran as Executive Director
HONG KONG, Feb. 8, 2021 /PRNewswire/ -- CareCapital Advisors Limited ("CareCapital") announces the appointment of Mr. A P A Bindusaran as Executive Director and Head of DSO Clinical and Business Development. Prior to joining CareCapital, Mr. Bindusaran spent 16 years in R&D, clinical affairs, tre...
2021-02-08 18:14
1902
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab
SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the commencement of a proposed registered underwritten pu...
2021-02-06 06:27
9586
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S.
SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced multiple clinical advancements for its proprieta...
2021-02-05 21:00
6003
111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services
SHANGHAI, Feb. 5, 2021 /PRNewswire/ -- On January 11, 2021, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jilin Baiyi Doctor Group Management Co., Lt...
2021-02-05 19:00
5584
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China
SHANGHAI and GAITHERSBURG, Md., Feb. 4, 2021 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in a phase 2 clinic...
2021-02-04 21:00
5409
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries
TAIPEI, Feb. 4, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132)("GoldenBiotech"), a leading Taiwanese biopharmaceutical company, announced that it has made two achievements for its Covid-19 new drug candidate Antroquinonol® (HOCENA®): receiving positive response after DMC review in Ph...
2021-02-04 18:41
2308
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab
BOSTON and BEIJING, Feb. 3, 2021 /PRNewswire/ -- Eucure Biopharma, a biopharmaceutical company dedicated to developing immuno-oncology antibody drugs, announced that its investigational anti-CD40 antibody drug (YH003), when combined with Junshi Biosciences' anti-PD-1 antibody Toripalimab (TUOYI®)...
2021-02-03 23:45
5909
Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program
NEW YORK, Feb. 3, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onFebruary 3, 2021, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Liv...
2021-02-03 22:00
7344
More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept
CHENGDU, China, Feb. 3, 2021 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group ("Kanghong", SHE: 002773), has received Special Protocol Assessments from the Food and Drug Administration for three new indications for its biologic drug conbercept. The drug is an anti-VEGF fusion protein, approv...
2021-02-03 22:00
4682
Latest Cigna International Markets Well-being Pulse Study Shows Global Populations Adapting but the COVID-19 Pandemic is Negatively Impacting People's Views of the Future
BLOOMFIELD, Conn., Feb. 2, 2021 /PRNewswire/ -- Cigna's (NYSE:CI) International Markets business has published its fourthCOVID-19 Global Impact Study. This series, which builds on Cigna's annual 360 Well-being Study, provides further insight into the global impact of the COVID-19 pandemic on peop...
2021-02-02 23:00
9494
Dyadic and TurtleTree Scientific enter strategic partnership
SAN FRANCISCO, Feb. 2, 2021 /PRNewswire/ -- Dyadic International, Inc.
2021-02-02 22:00
1626
China Jo-Jo Drugstores Releases 2020 Letter from the Chairman
HANGZHOU, China, Feb. 2, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, released a letter to sha...
2021-02-02 21:30
5155
Happiness Biotech Launched Auto Sales Platform "Happy Auto"
NANPING, China, Feb. 2, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company officially launched B2B auto sales platform "Happy Auto". The auto business was ...
2021-02-02 21:00
3920
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided a business update and announced the appointment of a new Chief Financial Officer, Mr. Terig Hughes, in addition to the appointment of Dr.Gaetan Michel as Chief Operating Officer, Mr. G...
2021-02-02 20:45
6911
Nippon Express (Thailand) Obtains GDP Certification for Domestic Transport Services
TOKYO, Feb. 2, 2021 /PRNewswire/ -- Nippon Express (Thailand) Co., Ltd. (hereinafter, "NE Thailand"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has obtained Good Distribution Practice (GDP) certification effectiveTuesday, December 22, 2020, evidencing its compliance with stand...
2021-02-02 14:00
1740
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 313 media titles]
2025-12-04 10:15
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 296 media titles]
2025-12-04 16:00
SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 295 media titles]
2025-11-29 09:00
Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2946
